Farmafender SRL
Farmafender reported total assets of 269,880 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jul 2026).
The score of Farmafender shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +260 % Total assets +154 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmafender's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 70,343 € | ||||
| Equity | 169,514 € | ||||
| Cash | 16,186 € | ||||
| EBITDA | 94,403 € | ||||
| Total assets | 269,880 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jun 2024
- Year ended 31 Dec 2022filed on 17 Jul 2023
- Year ended 31 Dec 2021filed on 18 Jul 2022
Farmafender's financial analysis
- Solvency62.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmafender
Farmafender's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0819.991.676
- VAT number
- BE0819991676
- Peppol
- Registered · 0208:0819991676 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Oct 2009
- Registered office
- 8210 Zedelgem
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Farmafender (SRL) has been based in Zedelgem since 2009, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 70,343 € and equity of 169,514 €; its revenue is not published. Its solvency stands at 62.8%, above the median of its sector (44.2%).
Companies similar to Farmafender
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Liwoma Retail sale of pharmaceutical products Kontich · balance sheet 289,010 €
- D-Pharma Retail sale of pharmaceutical products Brasschaat · balance sheet 226,463 €
- White-TO-Black Retail sale of pharmaceutical products Dilbeek · balance sheet 209,334 €
- AVA-Rose Retail sale of pharmaceutical products Jette · balance sheet 381,859 €
- Sarina Janssens Farma Retail sale of pharmaceutical products Bierbeek · balance sheet 136,654 €
- Karbon Plus Retail sale of pharmaceutical products Diksmuide · balance sheet 127,790 €
- Apocurae Retail sale of pharmaceutical products Kortemark · balance sheet 124,948 €
Frequently asked questions about Farmafender
What is the revenue of Farmafender?
Farmafender files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farmafender?
In Belgium, the VAT number is the company number prefixed with BE: BE0819991676 for Farmafender, if the company is VAT-registered. Its company number (CBE) is 0819.991.676.
Where is the registered office of Farmafender?
According to the CBE register, the registered office of Farmafender is in 8210 Zedelgem.
What is the equity of Farmafender?
At the close of the 2025 financial year, the equity of Farmafender amounts to 169,514 €, a solvency of 62.8% of total assets.
Who manages Farmafender?
The register lists 1 active mandates at Farmafender. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmafender
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →